Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

5.02
BATS BZX Real-Time Price
As of 11:16am ET
 -0.14 / -2.71%
Today’s Change
3.66
Today|||52-Week Range
6.64
+9.13%
Year-to-Date
No recent news for Chimerix Inc.

Today’s Trading

Previous close5.16
Today’s open5.18
Day’s range5.02 - 5.18
Volume2,479
Average volume (3 months)189,642
Market cap$242.8M
Dividend yield--
Data as of 11:16am ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+38.20%
Earnings growth (this year)-1.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.02%
P/E ratioNM
Price/Sales37.33
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.15-1.85%
ALBOAlbireo Pharma Inc-0.40-1.50%
NBRVNabriva Therapeutics...+0.07+1.05%
SBBPStrongbridge Biophar...-0.03-0.41%
Data as of 11:03am ET, 10/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$5.7M
Annual profit (last year)-$76.4M
Net profit margin-1,339.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts